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A B S T R A C T
This is the ﬁrst case report to describe the EEG ﬁndings in a patient with DiGeorge syndrome who
survived into adulthood. The patient developed generalized tonic–clonic seizures when she was 9 years
old and these were associated with hypocalcemia. Despite treatment with calcium, seizures persisted
and the patient required antiepileptic medications. She was eventually controlled with oxcarbazepine.
AnMRI of the headwas normal. An EEG showed independent spike andwave discharges emanating from
the left temporal and right frontal region. The presence of focal ﬁndings on EEG, the lack of complete
response to calcium therapy, and the need for antiepileptic drug therapy indicate that some of these
patients may be inherently predisposed to developing epilepsy.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The microdeletion 22q11.2 syndrome is one of the more
common human deletion syndromes (1 in 4000 live births)1 and
encompasses several clinical entities. Between 35 and 90% of
patients clinically diagnosed with DiGeorge Syndrome (consisting
of cardiac abnormalities such as interrupted aortic arch, truncus
arteriosus and tetralogy of Fallot; hypoparathyroidism; and thymic
hypoplasia with secondary immunodeﬁciency) and 80–100% of
those with velocardiofacial syndrome (consisting of pharyngeal
dysfunction, cardiac anomalies, and dysmorphic facies) have this
hemizygous deletion.1–3 This deletion is also found in patientswith
CHARGE (coloboma, heart atresia, retardation of growth, genitour-
inary problems, and ear abnormalities) and conotruncal anomaly
face syndromes.1 The reason for these overlapping syndromes is
the enormous phenotypic heterogeneity found with mutations of
chromosome 22q11.2. DiGeorge syndrome was ﬁrst described in
1968 as a defect affecting structures derived from the third and
fourth embryonic pharyngeal arches and pouches with absent or
small parathyroid glands.4 Many affected individuals die in the
neonatal period because of cardiac anomalies and susceptibility to
infections. Cardiac defects are found in 75% of patients.5* Corresponding author at: Department of Neurology, University of Florida
Health Science Center/Jacksonville, 580West Eighth Street, Tower One, Ninth Floor,
Jacksonville, FL 32209, United States.
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doi:10.1016/j.seizure.2009.07.003Information concerning the neurologic manifestations of
patients with 22q11.2 deletion who survive into adulthood is
scarce. We report a case of an individual with DiGeorge syndrome
whose seizures began in childhood and continued into the adult
years and present the EEG ﬁndings. The information garnered from
this case provides additional clinical insights on this relatively
common condition.
2. Case report
A 21-year-old female was referred to our service due to
seizures. She was born full-term, weighing 9-pounds and her
mother had an unremarkable pregnancy. However, during delivery
she became severely cyanotic. She was diagnosed as having both
Atrial Septal Defect (ASD) and Ventricular Septal Defect (VSD), and
these were repaired at 2 months of age. There was a question of
‘‘seizure-like’’ activity during her ﬁrst year of life and the patient
was brieﬂy placed on phenobarbital but this was subsequently
discontinued.
Her early medical history was signiﬁcant for mild psychomotor
retardation and the patient required special education. When the
patient was 9 years old she began to have generalized tonic–clonic
seizures lasting 2–3 min and occurring from wakefulness. At that
time, she was also diagnosed as having hypocalcaemia secondary
to hypoparathyroidism (total serum calcium of 7.8 mg/dl; N = 9–
10.5). Physical examination was remarkable for a short stature as
well as mild facial abnormalities such as micrognathia, hyperte-
lorism, and the absence of tonsils. A clinical suspicion of DiGeorgevier Ltd. All rights reserved.
Fig. 1. EEG shows independent spike and waves discharges over the left frontal (A) and right temporal (B) regions.
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conﬁrmed via FISH probe. Her parents were also tested for the
genetic deletion but the results were negative. There was no family
history of epilepsy.
The patient began treatment with calcium carbonate and
calcitriol. Despite the correction of her serum calcium, she
continued having seizures and was later placed on antiepileptic
medications including phenytoin, carbamazepine, and lamotri-
gine, all of which were associated with signiﬁcant sedation and
continuing seizures. Since 18 years of age, she has been on
oxcarbazepine monotherapy, with good seizure control and
tolerability.
A recent total calcium level was 8.1 mg/dl. The ionized calcium
was 3.6 mg/dl (N = 4.5–5.6) and the urine calcium/creatinine ratio
remained low despite medical treatment. A recentMRI of the brain
was normal. Her recent EEG showed independent spike and wave
discharges that emanated from the right temporal and the left
frontal area (Fig. 1). These abnormalities persisted despite the
patient having had no seizures for 3 years.3. Discussion
DiGeorge syndrome is a clinically variable syndrome consisting
of more than 180 potential clinical expressions.6 Due to its
enormous potential phenotypic expression, the diagnosis can be
challenging. However, the presence of cardiac defects, the
predisposition towards recurrent infections, and the presence of
distinct facial features allow the diagnosis to be usually made in
early infancy. Although the majority of cases are due to a partial
deletion of chromosome 22, several patients with the clinical
phenotype of DiGeorge syndrome have no known cause.1 The
diagnosis entails a high clinical suspicious and themicrodeletion in
chromosome 22 can be readily detected in both the prenatal and
postnatal periods by commercially available ﬂuorescent in-situ
hybridization (FISH) probes.2
Hypoparathyroidism is a common clinical manifestation in
22q11.2 deletion syndrome. It has been reported in 40–75% of
patients2,7 and is caused by absent or small parathyroid glands and
usually presents in the neonatal period as hypocalcemia. Al-Jenaidi
W. Gonza´lez, R.E.D. Bautista / Seizure 18 (2009) 648–651650et al.4 described 18 pediatric patients with 22q11.2 deletion
syndrome and hypoparathyroidism; of these 11 had complete
hypoparathyroidism while 7 had partial hypoparathyroidism.
Eight patients (72%) with complete hypoparathyroidism had
hypocalemic seizures, whereas only 2 patients with partial
hypoparathyroidism (28%) presented with seizures secondary to
low serum calcium levels.
Cognitive disabilities are seen in 40–46% of individuals (higher
in familial syndromes than in de novo deletions) and are
accompanied by a delay in developmental and gross motor skills.2
Behavioral problems include attention deﬁcit-hyperactivity dis-
order, oppositional deﬁant disorder, anxiety, depression, social
withdrawal, and obsessive-compulsiveness. Affected individuals
have poor social skills and deﬁcits in attention and thought.2,5
Structural neurological abnormalities include cerebral atrophy,
cerebellar hypoplasia, cerebrovascular abnormalities, septum
pellucidum cyst, hydrocephalus, hypoplastic corpus callosum,
and the presence of enlarged ventricles.6
Seizures are also commonly encountered in patients with the
22q11.2 deletion syndrome. Though generally regarded are being
due to hypocalcemia, seizures also occur in normocalcemic
individuals. Kao et al.8 noted that the prevalence of a single
unprovoked seizure was around 7% in patients with the 22q11.2
deletion syndrome. In a large European-based population, Ryan
et al.5 reported the presence of seizures in 21% of patients with the
22q11.2 deletion syndrome. Two-thirds of patients with seizures
had documented hypocalcemia. Robin et al.9 found seizures in 15/
32 patients with the 22q11.2 deletion syndrome. Interestingly,
none of these were associated with hypocalcemia.
Cortical dysgenesis (speciﬁcally polymicrogyria) has been
reported in some patients with the 22q11.2 deletion syndrome.
The degree of polymicrogyria varies between both hemispheres
but is more pronounced over the perisylvian region. Some of the
clinical features of perisylvian polymicrogyria included cognitive
defects, oromotor dysfunction (dyspraxia), dysarthria, dysphagia,
drooling, and other signs of pseudobulbar palsy (9).
It has also been shown that the regions of cortical dysgenesis in
patients with the 22q11.2 deletion syndrome are inherently
epileptic. Sztriha et al.10 published the clinical and MRI ﬁndings
correlation in two 5-year-old patients with polymicrogyria. One of
their patients had refractory epilepsy and underwent a right
functional hemispherectomy. This patient became seizure-free
after surgery.
In general, seizures are one of the more common symptoms
associated with chromosomal abnormalities. Battaglia and Guer-
rini11 reported that epilepsy occurs in up to half of cases with
chromosomal deletion syndromes such as 1p36 deletion syndrome
(craniofacial malformation and mental retardation) and 4p
deletion syndrome (multiple congenital anomalities and mental
retardation). Seizures are even more prevalent (90%) in cases of
Angelman syndrome, an entity usually caused by a deletion of
region 15q11-q13. In patientswith trisomy 21 (Down’s syndrome),
epilepsy is documented in 5–10% of cases. In other cases, the
incidence of epilepsy have been poorly deﬁned, but reports of
seizures have been documented in cases of trisomy 12p, trisomy
8q, ring chromosome 14 syndrome, and Inv-dup 15.11,12 In general,
the clinical seizure pattern, age of onset, EEG ﬁndings, and
response to antiepileptic therapy are variable and not necessarily
associated with the severity of neuroimaging ﬁndings.
The vast majority of reports describe the seizure activity of
individuals with DiGeorge syndrome during their childhood years.
Part of the reason for this is that patients with this condition rarely
survive into adulthood. The 1-month mortality rate for this
condition is 55% and a 6-month mortality rate of 86% has been
reported, primarily due to congenital heart defects.1,6 Those who
survive into adulthood tend to have milder cardiac defects,minimal facial dysmorphisms and a normal immune system but
these represent less than 15% of the total cases.1 To the best of our
knowledge this is the ﬁrst case report to describe both the ongoing
seizure activity and EEG ﬁndings of an individual with DiGeorge
syndrome during the adult years.
Previous case reports have documented the progression of
seizures during adulthood in patients with DiGeorge syndrome but
did not include EEG ﬁndings. Kar et al.13 reported one case of a 24-
year-old woman with DiGeorge syndrome who had hypocalcemia
but without cardiac abnormalities. Tonelli et al.14 described a 40-
year-old man who had convulsions associated with marked
hypocalcemia. Seizures abated with normalization of his serum
calcium levels. Maalouf et al.15 described a 32-year-old man who
had his ﬁrst seizure at the age of 14 years that was associated with
hypocalcaemia. The patient became asymptomatic with oral
calcium replacement for the next 18 years until he discontinued
his medications. He then developed recurrent seizures with
hypocalcemia and chromosomal analysis then showed the
chromosome 22q11.2 deletion. Hirotani et al.16 reported a partial
DiGeorge syndrome diagnosed at the age of 34 years, though
generalized tonic–clonic seizures began when the patient was 3
years old.
Coppola et al.17 described the clinical and EEG ﬁndings of 2
pediatric patients with velocardiofacial syndrome. The ﬁrst patient
was a 12-year-old boy who began to have focal motor seizures
when he was 5 years old. The EEG showed interictal epileptiform
discharges emanating from the right centrotemporal region.
Seizures continued until the patient was 12 years old and
succeeding EEGs were normal. The second patient was a 6-year-
old boywho began to have convulsive seizureswhen he has 3 years
old. The EEGs showed occipital spike andwave discharges. Seizures
were controlled with valproic acid.
Roubertie et al.18 also reported both the clinical and EEG
ﬁndings of two pediatric patients with DiGeorge syndrome. The
ﬁrst patient was a neonate with symptomatic hypocalcemia, who
had focalmotor seizures and spike andwave discharges emanating
from the right centroparietal region. This patient required calcium
therapy as well as carbamazepine in order to achieve seizure
control. The second patient was a 6-year-old girl with absence
seizures and generalized 3-per-second spike and wave discharges.
This patient was treated with valproic acid and clobazam. Kao
et al.8 indicated that the breath of EEG ﬁndings of patients with
chromosome 22q11.2 deletion included both focal and multifocal
epileptiform activity.
Our patient had interictal epileptiform discharges emanating
independently from the left frontal and right temporal regions. This
ﬁnding suggests that our patient has localization-related epilepsy
and that she may have more than one focus of seizure onset.
The presence of seizures in DiGeorge syndrome patients always
obliges the physician to rule out and treat electrolyte abnormal-
ities. However, as shown in our patient and in others, addressing
the problem of hypocalcemia may not always result in complete
seizure control, and AED therapy is sometimes required. Despite
the normal MRI ﬁndings, the presence of persistent focal
epileptiform discharges such as those seen in our patient indicate
that some of these individuals are inherently epileptic.
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